New prescribing rules for Di-Gesic and Doloxene unclear

CONFUSION surrounds new regulations for prescribing Di-Gesic and Doloxene (dextropropoxyphene, DPP), despite the latest ruling by the Administrative Appeals Tribunal (AAT).

Please Login to Access Medical Observer

If you have an account select Login. If you are new to Medical Observer select Join.

Login Join

Author:

Neil Bramwell

Neil Bramwell is a regular feature writer and contributor for MO.